Clinical trial
Pivotal Validation Study of Salivary Biomarkers for the Risk Stratification of Patients With Lesions Suspicious for Oral Squamous Cell Carcinoma
NCT01587573 is registered in ClinicalTrials.gov with PeriRx as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pivotal Validation Study of Salivary Biomarkers for the Risk Stratification of Patients With Lesions Suspicious for Oral Squamous Cell Carcinoma
- Lead sponsor
- PeriRx
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 30, 2012
- Completion date
- December 31, 2018
- Enrollment
- 370 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
oral squamous cell carcinoma